The endogenous substrates of brain CYP2D.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  European Journal of Pharmacology

• Publication date

  2014-02-05

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ejphar.2013.12.025PMID 24374199
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sex Differences in

  2016cited by this paper
• Parkinson disease: from pathology to molecular disease mechanisms.

  2013cited by this paper
• Genomics of Dementia: APOE- and CYP2D6-Related Pharmacogenetics

  2012cited by this paper
• Serum dextromethorphan/dextrorphan metabolic ratio for CYP2D6 phenotyping in clinical practice

  2012cited by this paper
• Pharmacogenomics of CYP2D6: molecular genetics, interethnic differences and clinical importance.

  2012cited by this paper
• Genetic variation in CYP2D6 impacts neural activation during cognitive tasks in humans

  2012influential reference
• The neuroprotective enzyme CYP2D6 increases in the brain with age and is lower in Parkinson's disease patients.

  2012influential reference
• Can Parkinson's disease pathology be propagated from one neuron to another?

  2012cited by this paper
• High risk of lifetime history of suicide attempts among CYP2D6 ultrarapid metabolizers with eating disorders

  2011cited by this paper
• Understanding the determinants of selectivity in drug metabolism through modeling of dextromethorphan oxidation by cytochrome P450

  2011cited by this paper
• CYP2D6- and CYP3A-Dependent Enantioselective Plasma Concentrations of Ondansetron in Postanesthesia Care

  2011cited by this paper
• Cytochrome P450 enzymes in the brain: emerging evidence of biological significance.

  2011cited by this paper
• Sex Differences in 3,4-Methylenedioxymethamphetamine (MDMA; Ecstasy)-Induced Cytochrome P450 2D6 Inhibition in Humans

  2011cited by this paper
• Pharmacokinetics of endogenous substances: Some problems and some solutions

  2011cited by this paper
• CYP2D6 in the Brain: Impact on Suicidality

  2011cited by this paper
• Steroid regulation of drug-metabolizing cytochromes P450.

  2011cited by this paper
• Finite-time synchronization of coupled neural networks via discontinuous controllers

  2011cited by this paper
• Testosterone and its metabolites--modulators of brain functions.

  2011cited by this paper
• Cytochrome P450 mediates dopamine formation in the brain in vivo

  2011cited by this paper
• CYP2D6 polymorphism in patients with eating disorders

  2010cited by this paper
• Urinary dopamine in aromatic L-amino acid decarboxylase deficiency: the unsolved paradox.

  2010cited by this paper
• High Frequency of Occurrence of CYP2D6 Gene Duplication/Multiduplication Indicating Ultrarapid Metabolism Among Suicide Cases

  2010cited by this paper
• ABC transporters and cytochromes P450 in the human central nervous system: influence on brain pharmacokinetics and contribution to neurodegenerative disorders

  2010cited by this paper
• Cytochrome P450 2D6 enzyme neuroprotects against 1‐methyl‐4‐phenylpyridinium toxicity in SH‐SY5Y neuronal cells

  2010cited by this paper
• The ability of cytochrome P450 2D isoforms to synthesize dopamine in the brain: An in vitro study.

  2010influential reference
• A role for CYP in the drug–hormone crosstalk of the brain

  2010cited by this paper
• Substrate specificity, inhibitors and regulation of human cytochrome P450 2D6 and implications in drug development.

  2009cited by this paper
• Effect of Pregnancy on the Pharmacokinetics of Antihypertensive Drugs

  2009cited by this paper
• Relation between CYP2D6 genotype, personality, neurocognition and overall psychopathology in healthy volunteers.

  2009cited by this paper
• CYP2D6: novel genomic structures and alleles

  2009cited by this paper
• CYP2D6 genotyping for functional-gene dosage analysis by allele copy number detection.

  2009cited by this paper
• Xenobiotic-Metabolizing Enzymes and Transporters in the Normal Human Brain: Regional and Cellular Mapping as a Basis for Putative Roles in Cerebral Function

  2009cited by this paper
• Neuroactive steroid regulation of neurotransmitter release in the CNS: action, mechanism and possible significance.

  2009cited by this paper
• New insights into the structural characteristics and functional relevance of the human cytochrome P450 2D6 enzyme

  2009cited by this paper
• O-demethylation of dextromethorphan using microbial cultures.

  2009cited by this paper
• CYP2D6: a key enzyme in morphine synthesis in animals.

  2008cited by this paper
• CLINICAL STUDY: Endogenous morphine signaling via nitric oxide regulates the expression of CYP2D6 and COMT: autocrine/paracrine feedback inhibition

  2008cited by this paper
• Developmental Changes in Human Liver CYP2D6 Expression

  2008cited by this paper
• Changes in maternal liver Cyp2c and Cyp2d expression and activity during rat pregnancy.

  2008influential reference
• Xenobiotic metabolizing enzymes in the central nervous system: Contribution of cytochrome P450 enzymes in normal and pathological human brain.

  2008cited by this paper
• Effect of psychotropic drugs on the 21-hydroxylation of neurosteroids, progesterone and allopregnanolone, catalyzed by rat CYP2D4 and human CYP2D6 in the brain.

  2008cited by this paper
• Relation between CYP2D6 phenotype and genotype and personality in healthy volunteers.

  2008cited by this paper
• Chronic nicotine treatment induces rat CYP2D in the brain but not in the liver: an investigation of induction and time course.

  2008cited by this paper
• Induction of the drug metabolizing enzyme CYP2D in monkey brain by chronic nicotine treatment.

  2008cited by this paper
• Alterations in drug disposition during pregnancy: implications for drug therapy.

  2007cited by this paper
• Molecular modeling-guided site-directed mutagenesis of cytochrome P450 2D6.

  2007cited by this paper
• ETHNIC VARIATION IN THE INCIDENCE OF ALS: A SYSTEMATIC REVIEW

  2007cited by this paper
• The Endomorphin System and Its Evolving Neurophysiological Role

  2007cited by this paper
• THE PROGRESSION OF PARKINSON DISEASE: A HYPOTHESIS

  2007cited by this paper
• The progression of Parkinson disease

  2007cited by this paper
• Aromatic L-amino acid decarboxylase enzyme activity in deficient patients and heterozygotes.

  2007cited by this paper
• Alterations in drug disposition during pregnancy:

  2007cited by this paper
• Catalytic site prediction and virtual screening of cytochrome P450 2D6 substrates by consideration of water and rescoring in automated docking.

  2006cited by this paper
• Cytochrome P450-mediated metabolism of estrogens and its regulation in human.

  2005cited by this paper
• Evaluation of dextromethorphan metabolism using hepatocytes from CYP2D6 poor and extensive metabolizers.

  2005influential reference
• Influence of age and gender on risperidone plasma concentrations

  2005cited by this paper
• Presence of splice variant forms of cytochrome P4502D1 in rat brain but not in liver.

  2005cited by this paper
• The Neurosteroids Progesterone and Allopregnanolone Reduce Cell Death, Gliosis, and Functional Deficits after Traumatic Brain Injury in Rats

  2005cited by this paper
• Cytochrome P450-mediated metabolism of melatonin.

  2005cited by this paper
• Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A Activity) during pregnancy.

  2005cited by this paper
• Chronic Nicotine Treatment and Retinal Development

  2005cited by this paper
• IN VITRO-IN VIVO EXTRAPOLATION OF CYP2D6 INACTIVATION BY PAROXETINE: PREDICTION OF NONSTATIONARY PHARMACOKINETICS AND DRUG INTERACTION MAGNITUDE

  2005cited by this paper
• Crystal Structure of Human Cytochrome P450 2D6*

  2005cited by this paper
• Effect of genetic polymorphism on the metabolism of endogenous neuroactive substances, progesterone and p-tyramine, catalyzed by CYP2D6.

  2004cited by this paper
• The Unique Regulation of Brain Cytochrome P450 2 (CYP2) Family Enzymes by Drugs and Genetics

  2004cited by this paper
• Cytochrome P450 2D catalyze steroid 21-hydroxylation in the brain

  2004influential reference
• CYP2D6 polymorphism, pesticide exposure, and Parkinson's disease

  2004cited by this paper
• Cytochrome P450 2D catalyze steroid 21-hydroxylation in the brain.

  2004cited by this paper
• CYP2D in the brain.

  2003cited by this paper
• Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms.

  2003cited by this paper
• Screening for endogenous substrates reveals that CYP2D6 is a 5-methoxyindolethylamine O-demethylase.

  2003cited by this paper
• The Danish University Antidepressant Group: Are gender differences important for the clinical effects of antidepressants?

  2003cited by this paper
• Regeneration of serotonin from 5-methoxytryptamine by polymorphic human CYP2D6.

  2003cited by this paper
• The Relative Contribution of Monoamine Oxidase and Cytochrome P450 Isozymes to the Metabolic Deamination of the Trace Amine Tryptamine

  2003cited by this paper
• Regulation of CYP2D expression in rat brain by toluene.

  2003cited by this paper
• Overexpression of CYP2D6 attenuates the toxicity of MPP+ in actively dividing and differentiated PC12 cells.

  2003cited by this paper
• Comparative molecular field analysis and QSAR on substrates binding to cytochrome p450 2D6.

  2003cited by this paper
• Oxidation of Methoxyphenethylamines by Cytochrome P450 2D6

  2002cited by this paper
• Regional and cellular expression of CYP2D6 in human brain: higher levels in alcoholics

  2002influential reference
• Role of biotransformation in conceptal toxicity of drugs and other chemicals.

  2001cited by this paper
• Comparative contribution to dextromethorphan metabolism by cytochrome P450 isoforms in vitro: can dextromethorphan be used as a dual probe for both CTP2D6 and CYP3A activities?

  2001cited by this paper
• Cellular localization and regional distribution of CYP2D6 mRNA and protein expression in human brain.

  2001cited by this paper
• Progesterone oxidation by cytochrome P450 2D isoforms in the brain.

  2001cited by this paper
• Regional and cellular distribution of CYP2D subfamily members in rat brain

  2000cited by this paper
• Recombinant cytochrome P450 2D18 metabolism of dopamine and arachidonic acid.

  2000cited by this paper
• Developmental changes in the catalytic activity and expression of CYP2D isoforms in the rat liver.

  1999cited by this paper
• Dopamine formation from tyramine by CYP2D6.

  1998cited by this paper
• Contribution of human hepatic cytochrome P450 isoforms to regioselective hydroxylation of steroid hormones.

  1998influential reference
• The association between polymorphisms in the cytochrome P-450 2D6 gene and Parkinson's disease: a case-control study and meta-analysis.

  1997cited by this paper
• Tryptamine: a possible endogenous substrate for CYP2D6.

  1997influential reference
• Induction of CYP2D6 in pregnancy

  1997cited by this paper
• Regulation of expression of cytochrome P-450 2D mRNA in rat brain with steroid hormones.

  1997cited by this paper
• The metabolism of tyramine by monoamine oxidase A/B causes oxidative damage to mitochondrial DNA.

  1996cited by this paper
• Anatomical distribution of NADPH-cytochrome P450 reductase and cytochrome P4502D forms in rat brain: Effects of xenobiotics and sex steroids

  1996cited by this paper
• P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature.

  1996cited by this paper
• cDNA cloning of a novel rat brain cytochrome P450 belonging to the CYP2D subfamily.

  1995influential reference
• Relationship between personality and debrisoquine hydroxylation capacity

  1993cited by this paper
• Variant cytochrome P450 CYP2D6 allelic frequencies in Parkinson's disease.

  1993cited by this paper
• Determination of 5-methoxyindoles in pineal gland and plasma samples by high-performance liquid chromatography with electrochemical detection.

  1991cited by this paper
• Expression of CYP2D6 in developing human liver.

  1991cited by this paper

• Assessment of In Vitro Antioxidant Activity and Subacute Toxicity and Safety of Tetrahydroserpentine in Hyperglycemic Mice

  2026cites this paper
• How cytochrome P450 enzymes in humans are involved in Parkinson's disease: a literature review.

  2026cites this paper
• Effects of Crocus sativus and its active constituents on cytochrome P450: a review

  2025cites this paper
• In Silico and In Vitro Analyses of Strawberry-Derived Extracts in Relation to Key Compounds’ Metabolic and Anti-Tumor Effects

  2025cites this paper
• Cisplatin-induced acute kidney injury increased brain 5-hydroxytryptamine levels partly due to the hippuric acid-induced upregulation of CYP2D4 expression and function in the brain of rats.

  2025cites this paper
• Effects of Berberis vulgaris, and its active constituent berberine on cytochrome P450: a review

  2024cites this paper
• Sex-specific effects of subchronic NMDA receptor antagonist MK-801 treatment on hippocampal gamma oscillations

  2024cites this paper
• Drug Metabolism Mechanisms And Pharmacokinetics Strategies In Implications For Drug Design: A Comprehensive Review

  2024cites this paper
• Human CYP2D6 varies across the estrous cycle in brains of transgenic mice altering drug response.

  2024cites this paper
• Possible Drug-Drug Interactions Between Mesalamine and Tricyclic Antidepressants Through CYP2D6 Metabolism – In silico and In vitro Analyses

  2024cites this paper
• NEW DRUGS ON THE PHARMACEUTICAL MARKET CONTAINING FLUORINE AND RESIDUES OF TAILOR-MADE AMINO ACIDS

  2024cites this paper
• Leveraging the Genetics of Psychiatric Disorders to Prioritize Potential Drug Targets and Compounds

  2024cites this paper
• The metabolic profiles of endogenous and exogenous substances in a poor metabolizer of humanized CYP2D6 model.

  2024cites this paper
• Stress Response of Neurotransmitters and Micro-RNAs 34c and 7a in Serum and Hypothalamus of Rats after Exposure to Different Powers of Noise

  2023cites this paper
• Associations between Selected ADRB1 and CYP2D6 Gene Polymorphisms in Children with Ventricular and Supraventricular Arrhythmias

  2023cites this paper
• Anti‐Epileptic Drug‐Lipid Conjugates for Delivery to the Brain: In Silico ADMET Prediction, Molecular Docking and Molecular Dynamics Simulations

  2023cites this paper
• Pharmacokinetic and safety profile of PT109B, a novel multi-targeted compound against Alzheimer's disease.

  2023cites this paper
• Age-related modifications in CYP-dependent drug metabolism: role of stress

  2023cites this paper
• Purkinje cell dopaminergic inputs to astrocytes regulate cerebellar-dependent behavior

  2023cites this paper
• The potential roles of amino acids and their major derivatives in the management of multiple sclerosis

  2022cites this paper
• Stress as a Potential Regulatory Factor in the Outcome of Pharmacotherapy

  2022cites this paper
• Joint Analysis of Phenotypic and Genomic Diversity Sheds Light on the Evolution of Xenobiotic Metabolism in Humans

  2022cites this paper
• In vitro effects and in silico analysis of newly synthetized pyrrole derivatives on the activity of different isoforms of Cytochrome P450: CYP1A2, CYP2D6 and CYP3A4

  2022cites this paper
• Sustained Release of Hydrogen Sulfide from Di(t-butanol)dithiophosphate Phenethylamine Salt Encapsulated into Poly(lactic acid) Microparticles to Enhance the Growth of Radish Plants

  2022cites this paper
• Dopamine, Immunity, and Disease

  2022cites this paper
• Current Knowledge and Novel Therapeutic Approaches Based on Pharmacokinetics and Pharmacodynamics in Stress-Induced Pathology

  2022cites this paper
• Dietary adaptation in Neandertal, Denisovan and Sapiens revealed by gene copy number variation

  2021cites this paper
• Clinical pharmacogenomics in action: design, assessment and implementation of a novel pharmacogenetic panel supporting drug selection for diseases of the central nervous system (CNS)

  2021cites this paper
• Impact of Using Organic Yeast in the Fermentation Process of Wine

  2021cites this paper
• Expression of the Tyrosine Hydroxylase Gene from Rat Leads to Oxidative Stress in Potato Plants

  2020cites this paper
• Insight into Ginkgo biloba L. Extract on the Improved Spatial Learning and Memory by Chemogenomics Knowledgebase, Molecular Docking, Molecular Dynamics Simulation, and Bioassay Validations

  2020cites this paper
• Sex steroid hormones differentially regulate CYP2D in female wild-type and CYP2D6-humanized mice.

  2020cites this paper
• Effect of N,N Coordination and RuII Halide Bond in Enhancing Selective Toxicity of a Tyramine-Based RuII (p-Cymene) Complex.

  2020cites this paper
• A Review on Electrochemical Sensors and Biosensors Used in Phenylalanine Electroanalysis

  2020cites this paper
• CYP1A1 and CYP2D6 Polymorphisms and Susceptibility to Chronic Myelocytic Leukaemia.

  2020cites this paper
• Expression of tyrosine hydroxylase gene from rat leads to oxidative stress in potato plants

  2020cites this paper
• Principles of Neurochemistry: Fundamentals and Applications

  2020cites this paper
• Chloroquine Phosphate Metabolism and Gender-based Phenotypic Analysis in Healthy Subjects’ Urine Following Oral Administration

  2020cites this paper
• A Review of the Important Role of CYP2D6 in Pharmacogenomics

  2020cites this paper
• Clinical response to cholinesterase inhibitors in dementia

  2020cites this paper
• Role of Chemical Agents in Nervous System: A Paradigm

  2020cites this paper
• Role of Yeast in Wine Fermentation Processes

  2020cites this paper
• CYP2D6 Pharmacogenetics Testing and Post–Cesarean Section Pain Scores—a Preliminary Study

  2019cites this paper
• Current trends in drug metabolism and pharmacokinetics

  2019cites this paper
• Benchmarking analysis of deleterious SNP prediction tools on CYP2D6 enzyme

  2019cites this paper
• Role of cytochrome P450 polymorphisms and functions in development of ulcerative colitis

  2019cites this paper
• Effect of copper nanoparticles on brain cytochrome P450 enzymes in rats.

  2019cites this paper
• Metabolic Characterization of Cellular Health Using a Multimodal Spectroscopy Technique

  2019cites this paper
• Kinetics of dextromethorphan-O-demethylase activity and distribution of CYP2D in four commonly-used subcellular fractions of rat brain

  2019cites this paper
• Benzene/toluene/water vapor adsorption and selectivity of novel C-PDA adsorbents with high uptakes of benzene and toluene

  2018cites this paper
• Dopamine and Serotonin Metabolism in Parkinsonian Models

  2018cites this paper
• A biochemical study of chronic stress and chronic inflammation fibromyalgia

  2018cites this paper
• Pharmacological treatment 7 Pharmacological Treatment of Parkinson ’ s Disease

  2018cites this paper
• The study of mRNA Expression of Dopamine Receptors D2 and D3 in Schizophrenic Patients

  2018cites this paper
• Pharmacological Treatment of Parkinson’s Disease

  2018cites this paper
• The Role of Dopamine in Primary Headaches

  2018cites this paper
• The engagement of brain cytochrome P450 in the metabolism of endogenous neuroactive substrates: a possible role in mental disorders

  2018cites this paper
• [Is it personalized treatment of dementia based on the CYP2D6 gene polymorphism possible?]

  2018cites this paper
• Cytochrome P450: Polymorphisms and Roles in Cancer, Diabetes and Atherosclerosis

  2018cites this paper
• ABCB1 and CYP2D6 polymorphisms and treatment response of psychotic patients in a naturalistic setting

  2018cites this paper
• A Three-Ring Circus: Metabolism of the Three Proteogenic Aromatic Amino Acids and Their Role in the Health of Plants and Animals

  2018cites this paper
• Antipyretic Effect of Herba Ephedrae-Ramulus Cinnamomi Herb Pair on Yeast-Induced Pyrexia Rats: A Metabolomics Study

  2018cites this paper
• Happy hormones and their significance in animals and man

  2018cites this paper
• CYP‐mediated drug metabolism in the brain impacts drug response

  2017cites this paper
• Further evidence for the association of CYP2D6*4 gene polymorphism with Parkinson’s disease: a case control study

  2017cites this paper
• Cytochrome P450 2D6 and Parkinson’s Disease: Polymorphism, Metabolic Role, Risk and Protection

  2017cites this paper
• Inducing rat brain CYP2D with nicotine increases the rate of codeine tolerance; predicting the rate of tolerance from acute analgesic response

  2017cites this paper
• The Pathophysiology of Heme in the Brain.

  2016cites this paper
• ssODN-mediated knock-in with CRISPR-Cas for large genomic regions in zygotes

  2016cites this paper
• Regulation of cerebral CYP2D alters tramadol metabolism in the brain: interactions of tramadol with propranolol and nicotine

  2015cites this paper
• Addressing phenoconversion: the Achilles' heel of personalized medicine

  2015cites this paper
• Sex hormones regulate cerebral drug metabolism via brain miRNAs: down‐regulation of brain CYP2D by androgens reduces the analgesic effects of tramadol

  2015cites this paper
• Impact of physiological, pathological and environmental factors on the expression and activity of human cytochrome P450 2D6 and implications in precision medicine

  2015cites this paper